Amprion attends the world’s leading neuroscience conferences, symposiums, and summits.
Amprion connects with breakthrough-seeking medical and research professionals to crack the code on precision medicine for Alzheimer’s, Parkinson’s, Lewy body dementia, and other neurodegenerative diseases through early detection. We look forward to meeting you!
January 29-31, 2025 | Amsterdam, Netherlands
March 12-15, 2025 | Quebec, Canada
April 1-5, 2025 | Vienna, Austria
April 5-9, 2025 | San Diego, CA, USA
July 27-31, 2025 | Toronto, Canada
October 5-9, 2025 | Honolulu, HI, USA
A pioneer in the science of detecting misfolded proteins, Amprion advances the diagnosis of brain disorders. Our SAAmplify™-ɑSYN Test aids physicians in diagnosing Parkinson’s, Lewy body dementia, and Alzheimer’s with Lewy body variant. We plan to launch more biomarker tests in the future.